Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status

about

Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells.

P2860

Q47341846-0888AB37-7D5F-4024-B59E-F7FB0C9620D3

P2860

Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status

Item

http://www.wikidata.org/entity/Q35921287

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Protease Activated Receptors 1 ...... s Depending on Tumor ER Status

@ast

Protease Activated Receptors 1 ...... s Depending on Tumor ER Status

@en

type

Item

label

Protease Activated Receptors 1 ...... s Depending on Tumor ER Status

@ast

Protease Activated Receptors 1 ...... s Depending on Tumor ER Status

@en

prefLabel

Protease Activated Receptors 1 ...... s Depending on Tumor ER Status

@ast

Protease Activated Receptors 1 ...... s Depending on Tumor ER Status

@en

P1476

Protease Activated Receptors 1 ...... s Depending on Tumor ER Status

@en

P2093

Carina Forsare

http://www.w3.org/2001/XMLSchema#string

Jon Lidfeldt

http://www.w3.org/2001/XMLSchema#string

Mårten Fernö

http://www.w3.org/2001/XMLSchema#string

Pär-Ola Bendahl

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombin receptor overexpression in malignant and physiological invasion processes

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer

Minireview: nuclear receptor coactivators--an update

Signaling of the tissue factor coagulation pathway in angiogenesis and cancer

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance

PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

P304

e0134932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0134932

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mattias Belting

Per-Uno Malmström

P577

2015-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280871764

http://www.w3.org/2001/XMLSchema#string

P698

26244666

http://www.w3.org/2001/XMLSchema#string

P932

4526525

http://www.w3.org/2001/XMLSchema#string

Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status

about

P2860

P2860

Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932